These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22204348)

  • 1. Recognition of nucleic acid ligands by toll-like receptors 7/8: importance of chemical modification.
    Yu H; Wang Z; Sun G; Yu Y
    Curr Med Chem; 2012; 19(9):1365-77. PubMed ID: 22204348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
    Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
    Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
    Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
    J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands.
    Zhang Z; Ohto U; Shibata T; Taoka M; Yamauchi Y; Sato R; Shukla NM; David SA; Isobe T; Miyake K; Shimizu T
    Cell Rep; 2018 Dec; 25(12):3371-3381.e5. PubMed ID: 30566863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structural Analyses of Toll-like Receptor Sensing Single-stranded Nucleic Acids and Its Application].
    Shimizu T
    Yakugaku Zasshi; 2016; 136(2):173-8. PubMed ID: 26831789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA recognition via TLR7 and TLR8.
    Hornung V; Barchet W; Schlee M; Hartmann G
    Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
    Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
    J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.
    Vasilakos JP; Tomai MA
    Expert Rev Vaccines; 2013 Jul; 12(7):809-19. PubMed ID: 23885825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, purification, and characterization of oligoribonucleotides that act as agonists of TLR7 and/or TLR8.
    Lan T; Kandimalla ER
    Methods Mol Biol; 2011; 764():249-61. PubMed ID: 21748646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of viral single-stranded RNA by Toll-like receptors.
    Diebold SS
    Adv Drug Deliv Rev; 2008 Apr; 60(7):813-23. PubMed ID: 18241955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9.
    Bauer S; Pigisch S; Hangel D; Kaufmann A; Hamm S
    Immunobiology; 2008; 213(3-4):315-28. PubMed ID: 18406377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic applications of nucleic acids and their analogues in Toll-like receptor signaling.
    Gosu V; Basith S; Kwon OP; Choi S
    Molecules; 2012 Nov; 17(11):13503-29. PubMed ID: 23151919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic agonists of Toll-like receptors 7, 8 and 9.
    Agrawal S; Kandimalla ER
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1461-7. PubMed ID: 18031246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
    Krieg AM; Vollmer J
    Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
    Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of nucleic acids by Toll-like receptors and development of immunomodulatory drugs.
    Kuznik A; Panter G; Jerala R
    Curr Med Chem; 2010; 17(18):1899-914. PubMed ID: 20377514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.
    Forsbach A; Samulowitz U; Völp K; Hofmann HP; Noll B; Tluk S; Schmitz C; Wader T; Müller C; Podszuweit A; Lohner A; Curdt R; Uhlmann E; Vollmer J
    Nucleic Acid Ther; 2011 Dec; 21(6):423-36. PubMed ID: 22196370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
    Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
    J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toll-like receptor 8: the awkward TLR].
    Alexopoulou L; Desnues B; Demaria O
    Med Sci (Paris); 2012 Jan; 28(1):96-102. PubMed ID: 22289837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.